Visiongain

'The global market for therapeutic respiratory devices will be worth $10.9bn by 2022' predicts new Visiongain's report

Press Release   •   Oct 05, 2012 15:34 BST

The market generated sales of $4.1bn in 2011. Key factors in the growth of this market will be the global aging population and the continued rise in chronic diseases and conditions such as obesity and diabetes, which continue to be considered significant risk factors in the development of several respiratory diseases. The therapeutic respiratory devices market is one of the fastest growing markets in the medical device industry. The market is currently comprised of innovative respiratory devices for the treatment of a wide range of disorders that include asthma, COPD, pulmonary fibrosis as well as sleep disorders such as Obstructive Sleep Apnea (OSA).

Rodrigo Gutierrez Gamboa, healthcare industry analyst, says: “Technological advancements and patient demand for homecare products that are more compact and user-friendly have propelled the field of respiratory devices in recent years. Furthermore, research regarding the causes of many respiratory disorders as well as their associations with other chronic conditions continues to accelerate. This will spur the introduction of innovative technologies for the treatment of a wide range of respiratory diseases that will drive the market forward in the coming years. Emerging markets will provide a significant commercial opportunity for companies operating in this industry as we expect them to continue expanding with a double-digit CAGR over the next decade”.
Visiongain’s research also suggests that the world therapeutic respiratory devices market may benefit from globalisation. There has been a steady rise in healthcare spending and medical insurance cover in countries such as Brazil, Russia, India and China (BRIC nations), owing to their rapidly growing economies. As a result, a greater proportion of the patient population will now be able to afford the treatments available, which will further strengthen demand in this sector.

Visiongain predicts that this market will grow steadily to 2022. The future of the therapeutic respiratory devices market appears promising and has significant potential for growth and investment with the increasing demand for safer and cost-effective therapies. This new report adds to visiongain’s wide range of analytical reports in healthcare and other industry areas.

For further information concerning the Visiongain’s Therapeutic Respiratory Devices: Global Market Outlook 2012-2022 report please visit http://www.visiongain.com/Report/905/Therapeutic-Respiratory-Devices-Global-Market-Outlook-2012-2022

Contact:
Email: Sara Peerun on sara.peerun@visiongainglobal.com
Tel: +44 (0) 20 7336 6100

ENDS

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain

Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Aviation and Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.